Early-Onset Alzheimer’s Disease
Release: June 15, 2021
Expiration: June 15, 2023
Faculty
Nick Fox is a professor of Clinical Neurology, the director of the Dementia Research Centre at the University College London’s Institute of Neurology and a group leader in the U.K. Dementia Research Institute. He is also a consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. His first degree was in physics and physiology at the University of Cambridge. He subsequently studied medicine at the University of London, specializing in cognitive neurology.
Fox runs a specialist cognitive disorders clinic and has long-standing clinical and research interests in younger-onset and familial dementias. He has been involved in dementia research for over 20 years, with particular interests in improving diagnosis and using imaging and other biomarkers to accelerate the search for effective therapies. Techniques that he developed to track disease progression using serial MRI have been used in more than 20 international clinical trials. He has contributed to a number of multimodal national and international longitudinal cohort studies in sporadic and familial Alzheimer’s disease and related disorders.
Fox has published over 450 papers and is a Web of Science Group highly cited researcher, ranking in the top 1% by citations. He is a member of the Alzheimer’s Society Research Strategy Council and was a member of the U.K. Prime Minister’s Dementia Research Champion’s Group. He received the 2017 Weston Brain Institute International Outstanding Achievement Award.
| Sponsorship | This is an Alzheimer’s Association activity |
| Copyright Statement with Logo | Home Office Alzheimer's Association Home Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 Alzheimer's Association is a not-for-profit 501(c)(3) organization. © 2021 Alzheimer’s Association®. All rights reserved.  |
| Disclaimer |
All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA- approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion. |
| Target Audience / Intended Audience | This activity is intended to meet the educational needs of primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia. |
| Statement of Need / Activity Purpose |
Attendees will be introduced to various research aspects of Alzheimer’s Disease and related dementias. |
| Learning Objectives |
During this session you will learn:
|
| Method of Participation |
This curriculum will take approximately 60 minutes to complete. In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com |
| Joint Providership Accreditation Statement | In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Alzheimer’s Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
| Credit Designation |
Physician Continuing Medical Education
Credit Designation- This program offers 1.0 continuing education credits for psychologists. Continuing Social Work Education As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits. |
| Faculty Disclosures |
Disclosures The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CME/ CE program: Faculty Name and Degree(s) Dr. Nick Fox has nothing to disclose. |
| Hardware and Software Requirements |
Hardware/Software Requirement:
|
